Keyword: series C

GenapSys has unveiled its compact, high-throughput DNA sequencer, alongside a $90 million venture capital raise to help jump-start its launch.

CMR Surgical raised £195 million, or about $240 million U.S., to fully fund the worldwide commercialization of its modular surgical robotics system.

Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new financing for its artificial intelligence programs.

To bring its nerve-stimulating wearable to market, Cala Health collected $50 million that it also plans to use to expand its therapeutic pipeline.

Poseida has put the kibosh on its IPO plans for now, settling instead for a $142 million series C round backed largely by Novartis.

Sight Diagnostics, maker of point-of-care blood diagnostic hardware, raised $27.8 million to continue its expansion and fund U.S. regulatory efforts.

Magnolia Medical Technologies raised $20 million in VC funding to scale up production of its Steripath device for reducing blood draw contamination.

Telehealth equipment maker Tyto Care raised an extra $9 million through its series C round, bringing its total up to $33.5 million.

Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology platform.

98point6, which makes primary care doctors available over cellphone messages, raised $50 million in a financing round led by Goldman Sachs.